The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan.
Hiramatsu N, Kasahara A, Nakanishi F, Toyama T, Tsujii M, Tsuji S, Kanto T, Takehara T, Kato M, Yoshihara H, Naito M, Katayama K, Hijioka T, Hagiwara H, Kubota S, Oshita M, Meren H, Masuzawa M, Haruna Y, Mita E, Suzuki K, Hayashi N.
Hiramatsu N, et al. Among authors: hagiwara h.
Hepatol Res. 2004 Jul;29(3):142-147. doi: 10.1016/j.hepres.2004.03.008.
Hepatol Res. 2004.
PMID: 15203077